NIP-221, a potent and long-acting thiazolidinedione insulin sensitizer, presented at the ADA meeting June 16, 2000
Chronic oral treatment with DP IV inhibitor P-32/98 provides good metabolic control in diabetic rats June 15, 2000
RSS